| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |